Events

03/13/2023

35th Annual Roth Conference

02/28/2023

Ocugen, Inc. Q4 and Full Year 2022 Financial Results and Business Highlights

02/06/2023

BIO CEO & Investor Conference

12/19/2022

Ocugen, Inc. to Ring the Nasdaq Stock Market Closing Bell

11/08/2022

Ocugen Inc Third Quarter 2022 Financial Results and Recent Business Highlights

11/01/2022

Ocugen R&D Day

10/04/2022

Chardan Genetic Medicines Conference

08/17/2022

H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

08/05/2022

Ocugen Inc Second Quarter 2022 Financial Results and Recent Business Highlights

06/13/2022

2022 BIO International Convention

05/24/2022

H.C. Wainwright Global Investment Conference

05/06/2022

Ocugen Inc First Quarter 2022 Financial Results and Recent Business Highlights

04/21/2022

Noble Capital Markets’ Eighteenth Annual Investor Conference

03/14/2022

34th Annual ROTH Conference

02/25/2022

Ocugen, Inc. Q4 and Full Year 2021 Financial Results and Recent Business Highlights

01/10/2022

H.C. Wainwright Bioconnect Conference

12/22/2021

CEO Shankar Musunuri on the power of Ocugen

11/09/2021

Ocugen Inc Third Quarter 2021 Financial Results and Recent Business Highlights

09/28/2021

2021 Cantor Virtual Global Healthcare Conference

09/13/2021

H.C. Wainwright Global Investment Conference